Publications and communications of Bernard DE PRIJCK

Bailleux, S., SOMJA, J., MARTIN, M., DE PRIJCK, B., & NIKKELS, A. (2022). HEREDITARY LEIOMYOMATOSIS AND ACUTE LYMPHOBLASTIC LEUKEMIA: a LINK THROUGH FUMARATE DYSHYDRATASE MUTATION? Acta Clinica Belgica, 77, 778-781. doi:10.1080/17843286.2021.1980669

LETE, C., FERNANDEZ CARAZO, R., MENTEN, C., BECKERS, P., KOOPMANSCH, B., FRANKE, S., DE PRIJCK, B., JAMAR, M., LAMBERT, F., & BOURS, V. (July 2021). A case of early-T-cell precursor acute lymphoblastic leukemia with e6a2 BCR-ABL1 fusion transcript [Poster presentation]. 13th European Cytogenomics Conference.

DE VOEGHT, A., JASPERS, A., BEGUIN, Y., Baron, F., & DE PRIJCK, B. (2021). Principes généraux de la prise en charges des leucémies aiguës de l’adulte en 2021 en Belgique. Revue Médicale de Liège, 76, 470-475.

MAQUET, C., BEGUIN, Y., DE PRIJCK, B., WILLEMS, E., SERVAIS, S., & BONNET, C. (2021). Le lymphome diffus à grandes cellules B : nouveau traitement révolutionnaire par des cellules immunitaires génétiquement modifiées appelées «CAR T cells». Revue Médicale de Liège, 76, 476-481.

Trimech, M., Letourneau, A., Missiaglia, E., DE PRIJCK, B., Nagy-Hulliger, M., SOMJA, J., Vivario, M., Gaulard, P., LAMBERT, F., Bisig, B., & de Leval, L. (2021). Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome. American Journal of Surgical Pathology, 45, 773-786. doi:10.1097/PAS.0000000000001646

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600

Vrancken, L., Muller, J., Lejeune, M., Grégoire, C., Delens, L., Jaspers, A., Servais, S., DE PRIJCK, B., Baron, F., Caers, J., & Beguin, Y. (2018). Nouveautes dans la prise en charge du myelome. Revue Médicale Suisse, 14 (615), 1438-1442.

Vekemans, M.-C., Beel, K., CAERS, J., Meuleman, N., Bries, G., Demuynck, H., DE PRIJCK, B., De Samblanx, H., Deweweirea, A., Fostier, K., Mineur, P., Vaes, M., Vande Broeck, I., Vande Velde, A., Van Droogenbroeck, J., Vlummers, P., Wu, K.-L., Schots, R., Delforge, M., & Doyen, C. (2017). Update on therapy of relapsed and refractory multiple myeloma. Belgian Journal of Hematology, 8, 53-65.

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845

SID, S., Baron, F., WILLEMS, E., Caers, J., Bonnet, C., DE PRIJCK, B., LEJEUNE, M., HAFRAOUI, K., Servais, S., JASPERS, A., & Beguin, Y. (November 2016). Hematologic recovery after autologus stem cell transplantation in multiple myeloma: a single center experience of 225 patients [Paper presentation]. 16ème Congrès commun de la SFGM-TC & 8ème de la SFBCT, Liège, Belgium.

WITHOFS, N., COUSIN, F., TANCREDI, T., SIMONI, P., DE PRIJCK, B., HAFRAOUI, K., BONNET, C., HUSTINX, R., BEGUIN, Y., & CAERS, J. (14 June 2016). Comparison of combined whole-body 18F-NAF and 18F-FDG PET/CT versus MRI for the detection of myeloma lesions [Paper presentation]. SNMMI 2016 Annual Meeting.

JASPERS, A., Baron, F., Maertens, J., DE PRIJCK, B., Schots, R., Bonnet, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & Beguin, Y. (July 2015). Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation [letter to the editor]. American Journal of Hematology, 90 (7), 133-4. doi:10.1002/ajh.24013

BONNET, C., Janssens, A., Wu, K., Schroyens, W., Van Hende, V., Heimann, P., Tousseyn, T., André, M., Bron, D., Van Hoof, A., Verhoef, G., DE PRIJCK, B., Beguin, Y., & Dierickx, D. (2015). BHS guidelines for the treatment of Burkitt lymphoma. Belgian Journal of Hematology, 6 (2), 61-69.

SID, S., Dugauquier, C., DE PRIJCK, B., BONNET, C., & Beguin, Y. (2015). Haemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 6 (2), 74-78.

JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948.

VALDES SOCIN, H. G., Potorac, I., DE PASQUAL, A., BARON, F., DE PRIJCK, B., Beguin, Y., & Beckers, A. (2014). Leucémie myéloblastique aiguë : sécrétion paranéoplasique de GH et de PRL ? In Abstract book - Annales d'Endocrinologie : 31ème Congrès de la Société Françaose d'Endocrinologie, Lyon 5-8 novembre 2014.

André, M., DE PRIJCK, B., Kentos, A., Van Hoof, A., Bonnet, C., Sonet, A., Maerevoet, M., Van Den Neste, E., Bosly, A., & Mounier, N. (2014). ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of LYSA H34 trial. Belgian Journal of Hematology, 12.

SID, S., Dugauquier, D., DE PRIJCK, B., Bonnet, C., & Beguin, Y. (2014). Hemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 17-18.

DE PRIJCK, B., HAYETTE, M.-P., & MISTRETTA, V. (19 December 2013). Alliance diagnostique et thérapeutique contre les mycoses invasives [Paper presentation]. Formation continue de Biologie Clinique, Liège, Belgium.

CAERS, J., Vekemans, M.-C., Bries, G., Beel, K., Delrieu, V., Deweweire, A., Demuynck, H., DE PRIJCK, B., De Samblanx, H., Kentos, A., Meuleman, N., Mineur, P., Offner, F., Vande Broek, I., Van Droogenbroeck, J., Vande Velde, A., Wu, K.-L., Delforge, M., Schots, R., & Doyen, C. (September 2013). Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians. Annals of Medicine, 45, 413-422. doi:10.3109/07853890.2013.801562

BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552

COLLINS, P., Vijgen, S., DE PRIJCK, B., BLETARD, N., Beguin, Y., & Delvenne, P. (2013). Chimiothérapie, immunodépression et cancers secondaires : rapport d'un cas clinique. Revue Médicale de Liège, 67, 418-422.

HAFRAOUI, K., DE PRIJCK, B., & Beguin, Y. (2013). Leucémie myélomonocytaire chronique : diagnostic et thérapeutique. Revue Médicale Suisse, 9, 1512-1517.

Van Obbergh, F., Van Hoof, A., Verhoef, G., Dierickx, D., De Wilde, V., Offner, F., Bron, D., Sonet, A., André, M., Janssens, A., Bonnet, C., DE PRIJCK, B., Zachée, P., Kentos, A., Schroyens, W., & Van Den Neste, E. (2013). Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS). Belgian Journal of Hematology, 4 (3), 90-101.

Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90.

FRUSCH, N., SERVAIS, S., DE PRIJCK, B., Corhay, J.-L., Beguin, Y., Louis, R., & DUYSINX, B. (2012). Spontaneous pneumomediastinum caused by bleomycin-induced pneumonitis. Acta Clinica Belgica, 67-68. doi:10.2143/ACB.67.5.2062693

Malaise, O., FRUSCH, N., BECK, E., Servais, S., BETEA, D., CAERS, J., DE PRIJCK, B., & BEGUIN, Y. (2012). Panhypopituitarism and diabetus insipidus in a patient with primary central nervous system lymphoma. Leukemia and Lymphoma, 53 (12), 2515-16.

Phan-Ba, R., Bisig, B., Deprez, M., DE PRIJCK, B., DELRUE, G., HERENS, C., Moonen, G., Belachew, S., & de Leval, L. (June 2011). Primary central nervous system lymphoma in a patient treated with Natalizumab. Annals of Neurology, 69 (6), 1060-1. doi:10.1002/ana.22296

Bonnet, C., CAERS, J., DE PRIJCK, B., HAFRAOUI, K., & Beguin, Y. (2011). Lymphome du manteau : prise en charge 2011. Revue Médicale Suisse, 7, 1644-1649.

CAERS, J., BONNET, C., GRAUX, C., DE PRIJCK, B., & BEGUIN, Y. (2011). Prise en charge actuelle des syndromes myélodysplasiques. Revue Médicale Suisse, 7, 1634-1643.

Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176.

Schots, R., Delforge, M., André, M., Bries, G., CAERS, J., Demuynck, H., DE PRIJCK, B., De Samblanx, H., Kentos, A., Meuleman, N., Offner, F., Vekemans, M., Vande Broek, I., Van Droogenbroeck, J., Van de Velde, A., Wu, K., & Doyen, C. (2010). The Belgian 2010 consensus recommendations for the treatment of multiple myeloma. Acta Clinica Belgica, 65, 252-264. doi:10.1179/acb.2010.055

Servais, S., Caers, J., Warling, O., Frusch, N., Baron, F., De Prijck, B., & Beguin, Y. (2010). Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma. British Journal of Haematology, 150 (3), 379-381. doi:10.1111/j.1365-2141.2010.08202.x

Beguin, Y., Maertens, J., DE PRIJCK, B., Schots, R., Frère, P., Bonnet, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., LEJEUNE, M., SERVAIS, S., THeunissen, K., Fillet, G., & Baron, F. (2009). A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation [Poster presentation]. 24th General Meeting of the Belgian Hematological Society, Oostende, Belgium.

Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7.

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.

Dugauquier, C., Bataille, Y., Willems, E., Frere, P., De Prijck, B., Beguin, Y., & Baron, F. (2009). Toxoplasmore cérébrale compliquant une mini-allogreffe de cellules souches hématopoïétiques du sang périphérique. Revue Médicale de Liège, 64 (7-8), 366-369.

GULBIS, B., FERSTER, A., VERMYLEN, C., DRESSE, M.-F., VANDERFAEILLIE, A., DELANNOY, A., LABARQUE, V., PHILIPPET, P., KENTOS, A., SZTERN, B., DE PRIJCK, B., & VERTONGEN, F. (2008). An estimation of the incidence and demographic picture of the major hemoglobinopathies in Belgium (from a confidential inquiry). Hemoglobin, 32 (3), 279-85. doi:10.1080/03630260802004400

Hustinx, R., Jerusalem, G., & De Prijck, B. (2008). Tomographie à émission de positons et lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 32, 449-455. doi:10.1016/j.mednuc.2008.06.002

Lejeune, M., Beguin, Y., De Prijck, B., Fassotte, M.-F., Fillet, G., & Baron, F. (2008). Comment je traite...La leucémie myéloblastique aiguë (LMA) du sujet age en bon état général. Revue Médicale de Liège, 63 (2), 59-63.

Witvrouw, N., De Prijck, B., & Hustinx, R. (2008). Indications cliniques de la radiotherapie metabolique dans les lymphomes. Revue Médicale Suisse, 4 (168), 1818-22.

De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90.

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220

Bonnet, C., Fillet, G., Bosly, A., Van Hoof, A., Offner, F., Van Den Neste, E., DE PRIJCK, B., Deflandre, A., Gisselbrecht, C., & Reyes, F. (2003). Radiotherapy is unnecessary in elderly patients with localized aggressive non hodgkin's lymphoma: results of the LNH 93-4 study [Paper presentation]. 18th General Meeting of the Belgian Hematological Society, Brussels, Belgium.

Herens, C., Tassin, F., Lemaire, V., Beguin, Y., Collard, E., Lampertz, S., Croisiau, C., Desouter-Lecomte, M., DE PRIJCK, B., Longree, L., & Koulischer, L. (2000). Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. British Journal of Haematology, 110 (1), 214-6. doi:10.1046/j.1365-2141.2000.02142.x